Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.
Identifieur interne : 000310 ( PubMed/Corpus ); précédent : 000309; suivant : 000311Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.
Auteurs : Zhonghua Yang ; Xinghuan Wang ; Tongzu LiuSource :
- Urology [ 1527-9995 ] ; 2013.
English descriptors
- KwdEn :
- Aged, Aged, 80 and over, Electrosurgery (adverse effects), Follow-Up Studies, Humans, Lasers, Solid-State (adverse effects), Lasers, Solid-State (therapeutic use), Length of Stay, Male, Middle Aged, Operative Time, Prostatic Hyperplasia (complications), Prostatic Hyperplasia (surgery), Prostatism (etiology), Prostatism (surgery), Quality of Life, Thulium, Transurethral Resection of Prostate (methods), Urodynamics.
- MESH :
- chemical : Thulium.
- adverse effects : Electrosurgery, Lasers, Solid-State.
- complications : Prostatic Hyperplasia.
- etiology : Prostatism.
- methods : Transurethral Resection of Prostate.
- surgery : Prostatic Hyperplasia, Prostatism.
- therapeutic use : Lasers, Solid-State.
- Aged, Aged, 80 and over, Follow-Up Studies, Humans, Length of Stay, Male, Middle Aged, Operative Time, Quality of Life, Urodynamics.
Abstract
To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 18 months of follow-up.
DOI: 10.1016/j.urology.2012.08.069
PubMed: 23374815
Links to Exploration step
pubmed:23374815Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.</title><author><name sortKey="Yang, Zhonghua" sort="Yang, Zhonghua" uniqKey="Yang Z" first="Zhonghua" last="Yang">Zhonghua Yang</name><affiliation><nlm:affiliation>Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xinghuan" sort="Wang, Xinghuan" uniqKey="Wang X" first="Xinghuan" last="Wang">Xinghuan Wang</name></author><author><name sortKey="Liu, Tongzu" sort="Liu, Tongzu" uniqKey="Liu T" first="Tongzu" last="Liu">Tongzu Liu</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1016/j.urology.2012.08.069</idno><idno type="RBID">pubmed:23374815</idno><idno type="pmid">23374815</idno><idno type="wicri:Area/PubMed/Corpus">000310</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000310</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.</title><author><name sortKey="Yang, Zhonghua" sort="Yang, Zhonghua" uniqKey="Yang Z" first="Zhonghua" last="Yang">Zhonghua Yang</name><affiliation><nlm:affiliation>Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.</nlm:affiliation></affiliation></author><author><name sortKey="Wang, Xinghuan" sort="Wang, Xinghuan" uniqKey="Wang X" first="Xinghuan" last="Wang">Xinghuan Wang</name></author><author><name sortKey="Liu, Tongzu" sort="Liu, Tongzu" uniqKey="Liu T" first="Tongzu" last="Liu">Tongzu Liu</name></author></analytic><series><title level="j">Urology</title><idno type="eISSN">1527-9995</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Electrosurgery (adverse effects)</term><term>Follow-Up Studies</term><term>Humans</term><term>Lasers, Solid-State (adverse effects)</term><term>Lasers, Solid-State (therapeutic use)</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Operative Time</term><term>Prostatic Hyperplasia (complications)</term><term>Prostatic Hyperplasia (surgery)</term><term>Prostatism (etiology)</term><term>Prostatism (surgery)</term><term>Quality of Life</term><term>Thulium</term><term>Transurethral Resection of Prostate (methods)</term><term>Urodynamics</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Thulium</term></keywords><keywords scheme="MESH" qualifier="adverse effects" xml:lang="en"><term>Electrosurgery</term><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Prostatism</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Transurethral Resection of Prostate</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term><term>Prostatism</term></keywords><keywords scheme="MESH" qualifier="therapeutic use" xml:lang="en"><term>Lasers, Solid-State</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Aged, 80 and over</term><term>Follow-Up Studies</term><term>Humans</term><term>Length of Stay</term><term>Male</term><term>Middle Aged</term><term>Operative Time</term><term>Quality of Life</term><term>Urodynamics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 18 months of follow-up.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23374815</PMID><DateCreated><Year>2013</Year><Month>02</Month><Day>04</Day></DateCreated><DateCompleted><Year>2013</Year><Month>04</Month><Day>19</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1527-9995</ISSN><JournalIssue CitedMedium="Internet"><Volume>81</Volume><Issue>2</Issue><PubDate><Year>2013</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Urology</Title><ISOAbbreviation>Urology</ISOAbbreviation></Journal><ArticleTitle>Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.</ArticleTitle><Pagination><MedlinePgn>396-400</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.urology.2012.08.069</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0090-4295(12)01153-3</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 18 months of follow-up.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study randomized 158 consecutive patients with BPH to ThuLEP (n = 79) or PKRP (n = 79). All patients were evaluated preoperatively and at 1, 3, 6, 12, and 18 months after surgery by International Prostate Symptom Score (IPSS), quality of life score (QOLS), maximum flow rate (Qmax), and postvoid residual urine volume (PVR).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The 79 patients in each study arm each showed no significant difference in preoperative parameters. Compared with PKRP, ThuLEP required a longer operation time (65.4 vs 47.4 minutes, P = .022) but resulted in less hemoglobin decrease (0.15 vs 0.30 g/dL, P = .045). ThuLEP also needed less catheterization time (2.1 vs 3.5 days, P = .031), irrigation volume (12.4 vs 27.2 L, P = .022), and hospital stay (2.5 vs 4.6 days, P = .026). During the 1, 3, 6, 12, and 18 months of follow-up, the procedures did not demonstrate a significant difference in Qmax, IPSS, PVR, and QOLS.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">ThuLEP and PKRP both relieve lower urinary tract symptoms equally, with high efficacy and safety. ThuLEP was statistically superior to PKRP in blood loss, catheterization time, irrigation volume, and hospital stay but inferior to PKRP in operation time. However, procedures did not differ significantly in Qmax, IPSS, PVR, and QOLS through the 18 months of follow-up.</AbstractText><CopyrightInformation>Copyright © 2013 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zhonghua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xinghuan</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Tongzu</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Urology</MedlineTA><NlmUniqueID>0366151</NlmUniqueID><ISSNLinking>0090-4295</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber><NameOfSubstance UI="D013932">Thulium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Urology. 2013 Feb;81(2):400-1; discussion 401</RefSource><PMID Version="1">23374816</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000369">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D004598">Electrosurgery</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005500">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053844">Lasers, Solid-State</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000009">adverse effects</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D007902">Length of Stay</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D061646">Operative Time</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000150">complications</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053448">Prostatism</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000209">etiology</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D020728">Transurethral Resection of Prostate</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000379">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D014563">Urodynamics</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2012</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2012</Year><Month>8</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pii">S0090-4295(12)01153-3</ArticleId><ArticleId IdType="doi">10.1016/j.urology.2012.08.069</ArticleId><ArticleId IdType="pubmed">23374815</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000310 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000310 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23374815
|texte= Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23374815" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |